August 20, 2008

Lawyers yesterday filed what is believed to be the first personal injury lawsuit stemming from injuries associated with the type 2 diabetes drug Byetta. Lawyers filed the lawsuit in San Diego Superior Court on behalf of a Virginia man who claims that Byetta’s manufacturer, Amylin Pharmaceuticals, Inc., and Byetta’s co-marketer, Eli Lilly and Company, failed to adequately test and monitor the side effects of Byetta. The plaintiff’s lawyers also allege that Byetta’s co-marketers failed to warn doctors or patients of the risk of developing pancreatitis.

Lawyers filed the first Byetta lawsuit just two days after the Food and Drug Administration (FDA) announced that it has received six reports of hemorrhagic or necrotizing pancreatitis in patients taking Byetta since October 2007. Two of the six patients died and the other four were hospitalized. In a press release issued two days ago, the FDA stated that it was working with Byetta’s maker to add stronger warnings to Byetta’s label.

In the fall of 2007, after the FDA received 30 post-marketing reports of acute pancreatitis associated with Byetta, Amylin agreed to add information about pancreatitis to the “precautions” section of Byetta’s label.

According to lawyers representing the plaintiff in the first Byetta lawsuit, “It is pretty obvious that the label change in 2007 was not adequate.” The plaintiff’s lawyers also stated, “We believe that Amylin possessed data prior to the 2007 label revision that justified a stronger and more prominent warning than the precaution language that Amylin ultimately negotiated with FDA.”

Although lawyers have already filed the first Byetta lawsuit, it is not too late for injured Byetta patients and their families to file a Byetta lawsuit. In fact, Byetta lawyers expect the number of Byetta lawsuits to skyrocket as awareness about the link between Byetta and serious side effects continues to rise.

Our Byetta side effects lawyers can advise Byetta patients and their families as to whether a lawsuit would be a feasible option. Contact us today.

Published November 17, 2011 by